Starting in 1993 and ending in 2001, ten academic medical centers in the United States screened 76,685 men and 78,216 women for prostate, lung, colorectal and ovarian cancers. The question was whether yearly screening could ...
Dec 8, 2016
0
4
In recent years, cancer patients have benefited from a new array of weapons to fight the disease. Traditional chemotherapy and radiation therapy—blunt clubs aimed at any fast-growing cell in the body—have been augmented ...
Dec 7, 2016
0
2
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the ...
Dec 5, 2016
0
0
Clinical trials have proven the power of immunotherapies targeting PD-L1 or PD-1 in a range of cancers. However, these same trials show that only some patients benefit - tumors must depend on PD-L1 to be affected when medicines ...
Dec 1, 2016
0
3
The Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital has received the highest accolade for its research work in the field of breast cancer: top medical journal The Lancet commissioned Michael ...
Nov 23, 2016
0
3
Neoadjuvant endocrine therapy - designed to reduce the size of breast tumors before surgical removal - appears to be as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast ...
Nov 9, 2016
0
4
A research team at Georgetown Lombardi Comprehensive Cancer Center has described the steps, in both written and video format, that allow cancer investigators to track, in real time, cancer cell invasion and metastasis in ...
Nov 3, 2016
0
2
(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 ...
Oct 31, 2016
0
1
The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759. The study will enroll patients ...
Oct 26, 2016
0
3
Parents of children newly diagnosed with cancer value the results of whole exome sequencing for a variety of reasons beyond clinical actionability, according to research presented at the American Society of Human Genetics ...
Oct 20, 2016
0
1
